GOP Bill Seeks To Expand Kentucky's Medical Marijuana Eligibility, Despite Pushback From Colleagues

Zinger Key Points
  • The new bill is viewed as a positive development among patient advocates & businesses looking to invest in Kentucky’s medical pot program.
  • The GOP caucus, which is divided over legalizing medical marijuana, will need to weigh in.

State Sen. Stephen West filed a bill to increase the number of eligible conditions for medical marijuana from six to 21, closely resembling the recommendations made by Gov. Andy Beshear and two committees that studied the issue.

West, one of the Republican supporters of medical marijuana legalization, said he's been working on the bill to expand qualifying conditions with Sam Flynn, the executive director of the Kentucky Medical Cannabis Program, reported WKYU on Monday.

"They were working in conjunction with us," West said. "We had multiple meetings during the interim. It’s with our blessing. I mean, it’s kind of a joint effort."

West's bill is viewed as a positive development among patient advocates and businesses looking to potentially invest in Kentucky's medical marijuana program, which will go into effect in January 2025.

That said, the bill will need support among the GOP caucus, which is divided over legalizing medical marijuana.

One GOP State Representative weighed in with a bill to not change the number of eligible medical conditions but conceded, sort of, to science

"If it’s appropriate that the market expands because that’s what the science tells us, then we’ll do that — increase conditions," said Jason Nemes. "But if it doesn’t, then we won’t. We’re not going to do it just to give them more customers."

Why Introduce The Same Bill Again?

While West said he agreed with adding nearly all of the conditions suggested by the governor in January, he noted there could be GOP legislators who supported the bill last year but who now object to some of them. West said the bill would likely be amended once it reaches the committee, so resubmitting makes sense.

"To me, those (conditions) all seem reasonable. But my view, my version of reasonable may be different than the other members," West said.

When Beshear introduced his bill expanding the list of qualifying conditions, he said it would increase the number of Kentuckians eligible for medical marijuana by 437,000.

West's new bill includes the following conditions: HIV/AIDS, ALS/Lou Gehrig’s disease, various forms of arthritis, cachexia, fibromyalgia, glaucoma, hepatitis C, Huntington’s disease, irritable bowel syndrome (including Crohn’s disease and ulcerative colitis), muscular dystrophy, neuropathies, Parkinson’s disease, sickle cell disease and any terminal illness.

Now Read: Wana Brands CEO Spearheads International Expansion In Cannabis Edibles Market

The Benzinga Cannabis Capital Conference is returning to Florida in a new venue in Hollywood on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn, and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars — this conference is the go-to event of the year for the cannabis world. Get your tickets now on bzcannabis.com – Prices will increase very soon!

Photo: Courtesy of Kindel Media by Pexels and Real Window Creative by Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsRegulationsTechnicalsPoliticsLegalTop StoriesGov. Andy BeshearKentuckymedical marijuana KentuckyState Sen. Stephen WestStories That Matter
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.